174 related articles for article (PubMed ID: 35437956)
1. Changes in transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 in patients with lower urinary tract dysfunction.
Cho KJ; Koh JS; Choi JB; Park SH; Lee WS; Kim JC
Investig Clin Urol; 2022 May; 63(3):309-315. PubMed ID: 35437956
[TBL] [Abstract][Full Text] [Related]
2. Expression of transient receptor potential vanilloid 4 and effects of ruthenium red on detrusor overactivity associated with bladder outlet obstruction in rats.
Cho KJ; Park EY; Kim HS; Koh JS; Kim JC
World J Urol; 2014 Jun; 32(3):677-82. PubMed ID: 23700140
[TBL] [Abstract][Full Text] [Related]
3. Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity.
Ha US; Park EY; Kim JC
Urology; 2011 Sep; 78(3):721.e1-721.e6. PubMed ID: 21782224
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.
Liu L; Mansfield KJ; Kristiana I; Vaux KJ; Millard RJ; Burcher E
Neurourol Urodyn; 2007; 26(3):433-8; discussion 439; discussion 451-3. PubMed ID: 17016800
[TBL] [Abstract][Full Text] [Related]
5. Urothelial Dysfunction, Suburothelial Inflammation and Altered Sensory Protein Expression in Men with Bladder Outlet Obstruction and Various Bladder Dysfunctions: Correlation with Urodynamics.
Jiang YH; Lee CL; Kuo HC
J Urol; 2016 Sep; 196(3):831-7. PubMed ID: 26930253
[TBL] [Abstract][Full Text] [Related]
6. Intravesical Activation of the Cation Channel TRPV4 Improves Bladder Function in a Rat Model for Detrusor Underactivity.
Deruyver Y; Weyne E; Dewulf K; Rietjens R; Pinto S; Van Ranst N; Franken J; Vanneste M; Albersen M; Gevaert T; Vennekens R; De Ridder D; Voets T; Everaerts W
Eur Urol; 2018 Sep; 74(3):336-345. PubMed ID: 29875065
[TBL] [Abstract][Full Text] [Related]
7. Increased TRPV4 expression in urinary bladder and lumbosacral dorsal root ganglia in mice with chronic overexpression of NGF in urothelium.
Girard BM; Merrill L; Malley S; Vizzard MA
J Mol Neurosci; 2013 Oct; 51(2):602-14. PubMed ID: 23690258
[TBL] [Abstract][Full Text] [Related]
8. Intravesical TRPV4 blockade reduces repeated variate stress-induced bladder dysfunction by increasing bladder capacity and decreasing voiding frequency in male rats.
Merrill L; Vizzard MA
Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(4):R471-80. PubMed ID: 24965792
[TBL] [Abstract][Full Text] [Related]
9. Differential localizations of the transient receptor potential channels TRPV4 and TRPV1 in the mouse urinary bladder.
Yamada T; Ugawa S; Ueda T; Ishida Y; Kajita K; Shimada S
J Histochem Cytochem; 2009 Mar; 57(3):277-87. PubMed ID: 19029406
[TBL] [Abstract][Full Text] [Related]
10. Smaller bladder capacity and stronger bladder contractility in patients with ketamine cystitis are associated with elevated TRPV1 and TRPV4.
Yang HH; Jhang JF; Hsu YH; Jiang YH; Zhai WJ; Kuo HC
Sci Rep; 2021 Mar; 11(1):5200. PubMed ID: 33664402
[TBL] [Abstract][Full Text] [Related]
11. Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells.
Li M; Sun Y; Simard JM; Chai TC
Neurourol Urodyn; 2011 Apr; 30(4):606-11. PubMed ID: 21351130
[TBL] [Abstract][Full Text] [Related]
12. Transient receptor potential vanilloid type 4 (TRPV4) in urinary bladder structure and function.
Perkins ME; Vizzard MA
Curr Top Membr; 2022; 89():95-138. PubMed ID: 36210154
[TBL] [Abstract][Full Text] [Related]
13. Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis.
Charrua A; Cruz CD; Jansen D; Rozenberg B; Heesakkers J; Cruz F
BJU Int; 2015 Mar; 115(3):452-60. PubMed ID: 25041193
[TBL] [Abstract][Full Text] [Related]
14. N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I.
Thorneloe KS; Sulpizio AC; Lin Z; Figueroa DJ; Clouse AK; McCafferty GP; Chendrimada TP; Lashinger ES; Gordon E; Evans L; Misajet BA; Demarini DJ; Nation JH; Casillas LN; Marquis RW; Votta BJ; Sheardown SA; Xu X; Brooks DP; Laping NJ; Westfall TD
J Pharmacol Exp Ther; 2008 Aug; 326(2):432-42. PubMed ID: 18499743
[TBL] [Abstract][Full Text] [Related]
15. Changes in Adenosine Triphosphate and Nitric Oxide in the Urothelium of Patients with Benign Prostatic Hyperplasia and Detrusor Underactivity.
Cho KJ; Koh JS; Choi J; Kim JC
J Urol; 2017 Dec; 198(6):1392-1396. PubMed ID: 28655527
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity.
Liu HT; Kuo HC
BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Chinese traditional prescription Suo Quan Wan on TRPV1 expression in the bladder of rats with bladder outlet obstruction.
Lai H; Tan B; Liang Z; Yan Q; Lian Q; Wu Q; Huang P; Cao H
BMC Complement Altern Med; 2015 Dec; 15():424. PubMed ID: 26627190
[TBL] [Abstract][Full Text] [Related]
18. Functional TRPV4 channels and an absence of capsaicin-evoked currents in freshly-isolated, guinea-pig urothelial cells.
Xu X; Gordon E; Lin Z; Lozinskaya IM; Chen Y; Thorneloe KS
Channels (Austin); 2009; 3(3):156-60. PubMed ID: 19411839
[TBL] [Abstract][Full Text] [Related]
19. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder.
Andersson KE; Gratzke C; Hedlund P
BJU Int; 2010 Oct; 106(8):1114-27. PubMed ID: 21156013
[TBL] [Abstract][Full Text] [Related]
20. Effect of SQW on the bladder function of mice lacking TRPV1.
Lai H; Yan Q; Cao H; Chen P; Xu Y; Jiang W; Wu Q; Huang P; Tan B
BMC Complement Altern Med; 2016 Nov; 16(1):465. PubMed ID: 27842583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
